How to Reconstitute Epithalon (Epitalon)
A laboratory guide to reconstituting Epithalon (Epitalon), covering the tetrapeptide's identifiers, its telomerase and ALT-related research, and the models those findings come from.
Epithalon — also written Epitalon or Epithalone — is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG), synthesized from the amino-acid composition of Epithalamin, a bovine pineal gland extract [6]. It is supplied as a lyophilized powder for laboratory research and is reconstituted by adding a suitable solvent to the vial and allowing the powder to dissolve completely before use. The evidence block for this page does not specify a solvent, a concentration, or a volume, so no reconstitution ratio is stated here; researchers should follow the documentation supplied with the specific lot.
The research literature on this compound centres on telomere maintenance, specifically telomerase activation via hTERT upregulation and, in some cell lines, alternative lengthening of telomeres (ALT) activity [4][5].
Research Studies
Epithalon and telomere length in human cell lines
Epitalon has been described as a naturally occurring tetrapeptide with reported anti-aging effects on mammalian cells, attributed to induction of telomerase enzyme activity and consequent extension of telomere length [4]. Telomere length is treated in that literature as a biomarker of aging, and the authors note that increasing or maintaining telomere length may contribute to healthy aging and longevity [4]. The same work states that quantitative data on the biomolecular pathway leading to telomere length increase — including hTERT mRNA expression, telomerase enzyme activity, and ALT activation — had not been extensive at the time of writing [4][5].
Epithalon and telomerase upregulation versus ALT activity
The mechanistic work distinguishes two routes by which telomere length may be extended in human cell lines: telomerase upregulation and ALT activity [4][5]. A correction notice has been issued for this study [3]. Both the primary report and the correction are listed in the Sources section below; anyone citing the findings should check the correction before relying on specific values.
Epithalon and the pineal tetrapeptide class
Epitalon is a tetrapeptide, Ala-Glu-Asp-Gly (AEDG), synthesized based on the amino acid composition of Epithalamin, a bovine pineal gland extract, prior to its discovery in pineal gland polypeptide complex solution [6]. Over roughly 25 years the compound has been studied using in vitro, in vivo, and in silico methods, with reported geroprotective and neuroendocrine effects attributed to antioxidant, neuroprotective, and antimutagenic activity arising from both specific and nonspecific mechanisms [6].
Epithalon and Epithalamin as distinct preparations
A narrative review reports that Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from the amino-acid composition of epithalamin, a pineal-derived polypeptide preparation, and states that although the two are historically related they are chemically distinct and their evidence should not be considered interchangeable [7].
| Preparation | Composition as reported | Evidence relationship |
|---|---|---|
| Epitalon / Epithalon | Synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG) [6][7] | Studied in vitro, in vivo, and in silico [6] |
| Epithalamin | Pineal-derived polypeptide preparation / bovine pineal gland extract [6][7] | Chemically distinct; evidence not interchangeable with Epitalon [7] |
Epithalon and hTERT in preclinical models
Current preclinical evidence suggests that Epitalon may activate telomerase by upregulating human telomerase reverse transcriptase (hTERT), and the same review reports work in aged primates [8]. These are preclinical findings; the evidence block does not supply human trial data for this endpoint.
Epithalon and delayed wound healing in a diabetic retinopathy model
In an in vitro model of diabetic retinopathy, the antioxidant tetrapeptide Epitalon was tested for its effect on delayed wound healing [10]. Diabetic retinopathy is described as the most common complication of diabetes mellitus and a leading cause of vision loss, and short peptides including di-, tri-, and tetrapeptides have been reported to carry antioxidant, antimicrobial, and anti-inflammatory activities [10]. This finding is from an in vitro system, not from human tissue.
Epithalon and therapeutic peptides in gerontology
A narrative review of therapeutic peptides in gerontology describes peptide therapeutics as an emerging frontier targeting hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline [2]. The review's stated objective was to assess mechanisms, clinical applications, evidence base, and safety profiles of peptides with demonstrated or potential applications in healthy aging and age-related conditions, drawing on PubMed, Scopus, and regulatory databases (FDA, WADA) from inception through January 2026 [2].
Epithalon and signalling pathways in orthopaedic peptide research
A review of therapeutic peptides in orthopaedics reports that peptides act on pathways including PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, and that this activity influences tissue regeneration [9]. That review concerns therapeutic peptides as a class rather than Epitalon specifically, and is included here as class-level context.
Epithalon and senescence-related chemoresistance in NKTCL
Separate work in natural killer/T-cell lymphoma (NKTCL), an aggressive haematological malignancy with poor prognosis in relapsed or refractory disease, established multidrug-resistant models using adriamycin and confirmed cellular senescence by markers including P16, P21, and senescence-associated β-galactosidase [1]. Proteomic sequencing of plasma from clinical patients and resistant cells identified LCP2 as a key protein, and phosphoproteomics, mass spectrometry, and co-immunoprecipitation were used in the analysis [1]. This study does not concern Epitalon; it is cited here only for the senescence-marker methodology it describes.
If you are reading this for personal health reasons
This material is sold for laboratory research only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.
Sources
- [1] LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma — https://europepmc.org/article/PMC/PMC13408427
- [2] Therapeutic peptides in gerontology: mechanisms and applications for healthy aging — https://europepmc.org/article/PMC/PMC13095733
- [3] Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — https://europepmc.org/article/PMC/PMC12619744
- [4] Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — https://europepmc.org/article/PMC/PMC12411320
- [5] Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity — https://doi.org/10.21203/rs.3.rs-7066545/v1
- [6] Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties — https://europepmc.org/article/PMC/PMC11943447
- [7] Epitalon and Epithalamin in Regenerative and Longevity Medicine: Mechanisms, Evidence, and Translational Gaps — https://doi.org/10.20944/preprints202609.0801.v1
- [8] From Cellular Aging to Tissue Protection: Epitalon in Regenerative and Longevity Medicine — https://doi.org/10.20944/preprints202607.2123.v1
- [9] Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — https://europepmc.org/article/PMC/PMC12753158
- [10] The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy — https://europepmc.org/article/PMC/PMC12356729